Abanoquil, a new alpha-1 adrenoceptor antagonist. In vitro and in vivo effect on erectile tissue

International Journal of Impotence Research

Volumn 12, Issue , 2000, Pages S37-S40

  Giraldi, A ^a   Wyllie, M ^b   Wagner, G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Urodoc   (United Kingdom)

Author keywords

Abanoquil; Alpha 1 adrenoceptor antagonist; Erectile dysfunction

Indexed keywords

ABANOQUIL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; PAPAVERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; ERECTILE DYSFUNCTION; MALE; MONKEY; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SWINE;

ADRENERGIC ALPHA-ANTAGONISTS; AMINOQUINOLINES; ANIMALS; MACACA FASCICULARIS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NOREPINEPHRINE; PAPAVERINE; PENILE ERECTION; PENIS; SWINE; TETRAHYDROISOQUINOLINES;

EID: 0034016881     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900505     Document Type: Article

References (17)

1. Stief CG et al. Cavernous smooth muscle changes during penile erection and sympathetic stimulation. Int J Imp Res 1991; 3: 15-20.
2. Andersson KE. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 1993; 45: 253-308.
3. Wagner G, Wei MQ. Alpha-a-adrenoceptor subtypes A and B exist in penile smooth muscle tissue. Int J Imp Res 1992; 4(Suppl 2): 42.
4. Traish AM, et al. Identification of alpha-1-adrenergic receptor subtypes in human corpus cavernosum tissue and in cultured trabecular smooth muscle cells. Receptor 1993; 5: 145-157.
5. Wagner G, Saenz de Tejada I. Update on male erectile dysfunction. BMJ 1998; 316: 678-682.
6. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191-236.
7. Adaikan PG. Pharmacology of the human penis. MSc. Thesis, University of Singapore, Singapore 1979, PP 1-213.
8. Willis E, et al. Vasoactive Intestinal Polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Acta Physiol Scand 1981; 113: 545-547.
9. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet 1982; II: 938.
10. Boolell M et al. Sildenafil: an orally active type 5 cyclic GMP- specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Imp Res 1996; 8: 47-52.
11. Fovaeus M, Andersson KE, Hedlund H. Effects of some calcium channel blockers on isolated human penile erectile tissue. J Urol 1987; 138: 1267-1272.
12. Giraldi A, Wagner G. Effects of pinacidil upon erectile tissue, in vitro and in vivo. Pharmacol Toxicol 1990; 67: 235-238.
13. Holmquist F, Andersson KE, Hedlund H. Effects of pinacidil on isolated human corpus cavernosum penis. Acta Physiol Scand 1990; 138(4): 463-469.
14. Brindley GS. Cavernosal alpha blockade: a new technique for investigating and treating impotence. Br JPsychiat 1983; 143: 332-337.
15. Blum MD, Bahnson RR, Porter TN, Carter MF. Effect of local alpha-adrenergic blockade on human penile erection. J Urol 1985; 134: 479-481.
16. Greengrass PM, Russel MJ, Wyllie MG. Abanoquil: a novel alpha- 1-adrenoceptor antagonist. BrJPharmacol 1991; 104: 321P.
17. Wulff HR, Schlichting P. Manual for MEDSTAT, Herlev University Hospital, November 1988.